Testing For Toxicity In Fertility Treatment Technologies
Executive Summary
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
You may also be interested in...
FDA Finalizes Guidance On Role Of Mouse Embryos In ART Device Toxicity Testing
The document from the US agency explains the recommended testing approach, as well as labeling strategy.
Merck On A Mission To Introduce Automation To Fertility Treatment
Healthcare giant Merck is on a mission to introduce automation to fertility treatment and improve patient outcomes. The German company, already a leader in fertility drugs, aims to expand its market position by delivering innovative device technologies.
FDA Inks Class II Designation For Embryo Viability Tests
The agency set a class II with special controls designation for assisted reproduction embryo image assessment systems in a Feb. 26 final order, following the de novo decision for Auxogyn’s Eeva system last summer.